Adma Biologics, Inc.
ADMA· Nasdaq
Released May 14, 2018, after the close
10-Q filed May 14, 2018, 44 days after period end · 0001193805-18-000666
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $4.04M | $2.63M | $2.12M | $1.50M |
| Net Income | -$17.82M | -$6.54M | -$4.61M | -$3.61M |
| EPS Diluted | -$0.39 |
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
| -$0.51 |
| -$0.43 |
| -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.